Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,598,776
+$6,598,776 QoQ
Shares Held
34,800
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#348
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$11,377,200
PutShares
60,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $56,332,097 across 7 Drug Manufacturers - General names. AZN ranks #4 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,000 | $15,238,200 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
100,000 | $12,634,000 | |
| 3 | LLY |
ELI LILLY & Co
|
9,100 | $10,914,813 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
34,800 | $6,598,776 | |
| 5 | NVO |
Novo Nordisk A S
|
103,132 | $4,944,148 | |
| 6 | BIIB |
Biogen Inc.
|
21,000 | $4,537,260 | |
| 7 | MRK |
Merck & Co., Inc.
|
11,400 | $1,464,900 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,377,200 | 60,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $6,598,776 | 34,800 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,833,200 | 60,000 | Put | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||